All Episodes

FDA Class I Recall: Aspergillus Contamination in IV-Start and Convenience Kits

Psilocybin May Ease Treatment-Resistant Depression

FDA Alert: Recall of Glutathione, Myers’ Cocktail and Tri-Immune Boost Injections

SGLT2 Inhibitors vs GLP-1 Receptor Agonists: What Cardiovascular Evidence Shows

FDA Approves First Treatment for MCT8 Deficiency

WHO Moves to Expand Access to Lifesaving Sickle Cell Treatment and Care for Children

Baxter Recalls One Lot of Cefazolin in Dextrose Injection After Cardboard Particles Found

Orforglipron Added to Insulin Glargine Improves HbA1c and Weight in Type 2 Diabetes

Ecopipam Shows Promise for Tourette Syndrome in Young People

Luna G3 APAP Recall Targets 20,000-Plus US Devices

Camizestrant Links ESR1 Detection to Breast Cancer Care

Halyard IV Start Kit Class I Recall Requires Fast Action

PiCardia ShortCut Recall Flags Positioning-Arm Risk

Sevabertinib Approved for HER2-Mutant Nonsquamous NSCLC

Lirafugratinib Expands FGFR2 Cholangiocarcinoma Options

Papaverine Injection Recall Raises Particulate Risk

Sevabertinib Approved for Advanced Non-Squamous NSCLC

Gastric Cancer EFS Improves With Perioperative Serplulimab

Recurrent C. Difficile Outcomes Favor FMT Over Antibiotics

Heart Failure Definition Update Across Care Settings

Preoperative Anemia: What ITACS Can—and Cannot—Change

Central Precocious Puberty: When Brain MRI Is Not Routine

Imlunestrant Combination Approved for ESR1 Breast Cancer

WHO Calls for Stronger Safety Monitoring as GLP-1 Use Expands

Esophageal pH Capsule Alert Signals Procedural Safety Risk

Baxdrostat Adds an Option for Uncontrolled Hypertension

Ebola and Marburg Clinical Care Standards Unified by WHO

Sacituzumab Tirumotecan Improves PFS in Advanced NSCLC

Sevabertinib Approval Narrows HER2-Mutated NSCLC Use

Dexcom Stelo Is First OTC Glucose Monitor for Children

Morphine Recall Tests Controlled-Drug Response Readiness

IV Fosphenytoin for Acute Trigeminal Neuralgia: What the Phase 3 Trial Means for Rescue Care

FDA Approves RefluxStop for GERD With Five-Year Post-Approval Study

Semaglutide and Cardiovascular Risk: What a 2026 Meta-Analysis Shows

Low-Dose Naltrexone Remains Unproven for Long COVID

Retatrutide Monotherapy in Early Type 2 Diabetes: Glycemic Control and Weight Loss

Antimicrobial Resistance Guidance Updates Treatment Choices

ATTR-CM Symptoms and Hospitalizations Improve With Acoramidis

Mortality Evidence for Stopping Statins After Age 75

Intrauterine hCG Does Not Improve IVF Live Birth Rates

Sevabertinib Makes HER2 Testing Actionable in NSCLC

Patient Assessment After Possible Recalled Tyenne Exposure

Zidesamtinib Offers a Post-TKI Option in ROS1 NSCLC

Postmenopausal Bleeding Guidance Refines Ultrasound Triage

Andes Virus Cluster Prompts Cruise Ship Case Protocols

Finerenone Benefits Span Blood Pressure in HFmrEF and HFpEF

Parkinson’s Disease Risks With Bilateral Focused Ultrasound

Adjuvant CDK4/6 Benefits Diverge in Early Breast Cancer

Adjuvant CDK4/6 Benefits Diverge in Early Breast Cancer

Sickle Cell Anemia Guidance Expands Hydroxyurea Access

Primary Aldosteronism Evidence Reshapes Care Pathways

WHO Updates COVID-19 Vaccine Priorities and Schedules

Zanidatamab Expands First-Line HER2-Positive GI Care

Deramiocel for Duchenne Muscular Dystrophy: FDA Review Raises Questions About Cardiac Benefit

Myeloma Survival Unchanged With Longer Lenalidomide

WHO Dementia Risk Guidance Needs Source Verification

Orlistat Kidney-Injury Warning Now Covers OTC Alli

Tocilizumab Recall Demands Rapid Inventory Controls

Advanced CKD: Rivaroxaban Adds Bleeding, Not Benefit

PD-L1 Testing Defines New First-Line Option in TNBC

Selpercatinib Expands RET Fusion Testing Across Tumors

Daraxonrasib Challenges Second-Line Pancreatic Cancer Care

Six-Month Strategy Holds Up in Rifampicin-Resistant TB

CKM Syndrome Guideline Standardizes Integrated Detection

Extended DAPT Results Need Verification After Multivessel PCI

Finerenone Shows Cardiovascular and Kidney Benefits Across CKM Stages in Type 2 Diabetes and CKD

SGLT Inhibitors in Heart Failure: Benefits Across Diabetes Status and Ejection Fraction

WHO Introduces Standardized Language for Hypertension Control Programs

WHO Revises Pediatric HIV Antiretroviral Dosing

Pluvicto Moves Earlier in PSMA-Positive Prostate Cancer

COVID-19 Device EUA Exit Reshapes US Procurement

Perioperative Pembrolizumab Expands in Bladder Cancer

CKM Guideline Sets Staged Risk and Atherogenic Goals

Hypertension Treatment Thresholds Across Risk Groups

Bladder Cancer Outcomes Favor Enfortumab–Pembrolizumab

Cyclosporiasis Outbreak Sharpens Need for Targeted Testing

Ensartinib Lowers Recurrence Risk in ALK-Positive NSCLC

Morphine Recall Raises Fatal Hydromorphone Substitution Risk

Heart Failure Diagnosis Under the Second Universal Definition

Teplizumab Expands to Pediatric Stage 3 Type 1 Diabetes

Enlicitide Adds an Oral Option for Hypercholesterolemia

Imaging May Extend Stroke Thrombolysis to 24 Hours

Atrial Fibrillation After PCI May Need 1-Month P2Y12

FDA Approves Tirzepatide for Obstructive Sleep Apnea

Semaglutide Improves Kidney Outcomes in Type 2 Diabetes

Decoding Rome V: Key Updates in Adult and Pediatric Gut-Brain Interaction Disorders

Earlier Intervention May Improve Aortic Regurgitation Outcomes

Cardio-Oncology: Protecting the Heart While Fighting Cancer

Sirolimus Conversion Improves Survival After Heart Transplant

Comparative Effectiveness & Safety of LAMA-LABA Inhalers in COPD

The Algorithm & TikTok Triage: What KFF’s Health Information Poll Means for Clinical Practice

Uncovering the Early-Life Roots of Early-Onset Colorectal Cancer

GLP-1 Receptor Agonists and the Reduction of Alcohol-Related Hospitalizations in Alcohol Use Disorder

Compounded Wellness Peptides Under Scrutiny: tECRI and ISMP Safety Warning

Hidden Arboviral Threat: The Oropouche Virus

Monoclonal Antibodies for Hyperlipidemia: How PCSK9 Inhibitors Lower LDL Cholesterol

Parental Stress Is a Public Health Issue: Why It Matters

A New Frontier in ADHD Pharmacotherapy: Centanafadine (SIMTRIYO®)

Drug-Related IE Now Majority Of Valve Surgeries In Some US Areas

What the FDA Approval and Phase 3 Data for Enlicitide Means for Preventive Cardiology